期刊文献+

伊布利特治疗房颤患者的观察及护理

Observation and nursing of atrial fibrillation patients with ibutlide
下载PDF
导出
摘要 目的:通过对使用伊布利特治疗房颤患者观察,给予及时正确护理。方法:遵医嘱采用30 min内静脉滴注1mg伊布利特,间隔10min,若未出现停止给药指标,再于10min内静脉注射1mg,静脉用药过程中严密观察血压、心率及心律变化。结果:28例房颤患者中22例转为窦性心律,未发生任何并发症,有效率为78.6%。结论:在使用伊布利特治疗房颤患者时要达到起效快,安全性高,必须严密观察及时护理。 Objection: Purpose: Observing the treatment to Atrial fibrillation patient with Ibutilide,finding the right way to give timely and effective nursing.Methods: According to the doctor's advice,intravenous infusing 1 mg Ibutilide within 30 minutes,and after 10 minutes,if there is no index that showing have to stop the medicine providing,infusing 1 mg more within 10 minutes.Carefully observing the blood pressure,heart rhythm and heart rate change during the intravenous infusion.Results: Among the observed 28 Atrial fibrillation patients,22 of them has turned to sinus heart rhythm and without any syndrome,effective rate is high to 78.6%.Conclusion: to achieve speedy effective and high level safety,close observation and duly nursing should be applied when using Ibutilide for Atrial fibrillation patients.
机构地区 安徽省立医院
出处 《安徽卫生职业技术学院学报》 2011年第5期63-64,共2页 Journal of Anhui Health Vocational & Technical College
关键词 伊布利特 房颤 护理 Ibutilide Atrial fibrillation Nursing
  • 相关文献

参考文献5

二级参考文献8

  • 1Miller MR, McNamara RL, Segal JB,et al. Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm: a Meta analysis of clinical trials. J Fam Pract,2000,49:1033-1046.
  • 2Cropp Js, Antal EG, Talbert RL,et al. Ibutilide: a new class Ⅲ antiarrhythmic agent. Parmarcotherapy, 1997,17:1-9.
  • 3Lych JR, Baskin EP, Nutt EM, et al, Comparision of binding to rapidly activating delayed rectifier K channel, Ikr and effects on myocardial refractoriness for class Ⅲ antiarrythmic agents. J Cardiovasc Pharmacol, 1995,25:336-340.
  • 4Naccarelli GV, Lee KS, Gibson JK, et al. Electrophysiology and pharmacology of Ibutilide. Am J Cardiol,1996,78(8A): 12-16.
  • 5Baskin EP , Lynch JJ Jr. Differential atrial versus ventricular activities of class Ⅲ potassium channel blockers. Pharmacol Exp Ther, 1998,285:135-142.
  • 6Ellenbogen KA, Stambler BS, Wood MA, et al . Efficacy of intravenous Ibutilide for rapid termination of atrial fibrillation and atril flutter: a dose-response study. J Am Coll Cardiol, 1996, 28: 130-136.
  • 7Gowdw RM, Punukollu G, Khan LA, et al. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety. Am J Ther, 2003,10: 259-263.
  • 8Kowey PR, Vanderlugt JT, Luderer JR. Safety and risk/benefit analysis of Ibutilide for acute conversion of atrial fibrillation/flutter. Am J Cardiol , 1996,78 (suppl 8A): 46-52.

共引文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部